| CAS NO: | 573691-09-5 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| Cas No. | 573691-09-5 |
| 别名 | 阿立哌唑-N1-氧化物 |
| Canonical SMILES | O=C1NC2=CC(OCCCC[N]3(CCN(CC3)C4=C(Cl)C(Cl)=CC=C4)=O)=CC=C2CC1 |
| 分子式 | C23H27Cl2N3O3 |
| 分子量 | 464.4 |
| 溶解度 | DMSO: soluble |
| 储存条件 | -20буC |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Aripiprazole N-oxide is a metabolite of the atypical antipsychotic aripiprazole .1,2It is formed from aripiprazole by the cytochrome P450 (CYP) isoforms CYP2D6 and CYP3A4.3Aripiprazole N-oxide is a potential impurity found in commercial preparations of aripiprazole.1 1.Filijovic, N.D., Pavlovi?, A., Nikolic, K., et al.Validation of an HPLC method for determination of aripiprazole and its impurities in pharmaceuticalsActa Chromatagr.26(1)13-28(2014) 2.Satyanarayana, B., Sumalatha, Y., Kumar, S.S., et al.Synthesis and characterization of N-oxides and metabolites of antipsychotic drug, aripiprazoleHeterocycl. Commun.11(6)485-490(2005) 3.Kubo, M., Koue, T., Inaba, A., et al.Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLEDrug Metab. Pharmacokinet.20(1)55-64(2005) |
m.cnreagent.com